We also analyzed LINC00152 expression levels and other clinical variables from this validation set, however, no evidence was obtained to support the association between LINC00152 expression and age, gender, smoking, differentiation, tumor stage, lymph node or KRAS mutation status (Supplementary Table 1). Here, KRAS is linked to neoplasm.